(Medical Xpress)—Researchers at UCLA's Jonsson Comprehensive Cancer Center have successfully combined cellular therapy and gene therapy in a mouse-model system to develop a viable treatment strategy for breast cancer that ...
Aug 6, 2013
0
0
Methamphetamine use can make a person more susceptible to the lung infection cryptococcosis, according to a study published in mBio, the online open-access journal of the American Society for Microbiology.
Jul 30, 2013
0
2
Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD).
Jul 29, 2013
0
0
A team of scientists has obtained intriguing insights into two groups of autism candidate genes in the mammalian brain that new evidence suggests are functionally and spatially related. The newly published analysis identifies ...
Jul 25, 2013
0
0
Key molecular pathways that ultimately lead to late-onset Alzheimer's disease, the most common form of the disorder, have been identified by researchers at Columbia University Medical Center (CUMC). The study, which used ...
Jul 24, 2013
0
0
Mouse embryos with the human enzyme CYP2C19 in the brain develop a smaller hippocampus and anxiety-like behaviour as adults. The results of this new study, which is published in the journal Molecular Psychiatry, agree in ...
Jul 24, 2013
0
1
A hallmark of neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's is that by the time symptoms appear, significant brain damage has already occurred—and currently there are no treatments that can ...
Jul 8, 2013
0
0
Scientists in Japan said Wednesday they had grown human liver tissue from stem cells in a first that holds promise for alleviating the critical shortage of donor organs.
Jul 3, 2013
0
0
Identification of a protein that appears to play an important role in the immune system's removal of amyloid beta (A-beta) protein from the brain could lead to a new treatment strategy for Alzheimer's disease. The report ...
Jul 1, 2013
0
0
Researchers at Columbia University Medical Center (CUMC) have demonstrated that a protein called caspase-2 is a key regulator of a signaling pathway that leads to cognitive decline in Alzheimer's disease. The findings, made ...
Jun 25, 2013
0
0
